secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001285550-24-000016
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports Q4 2023 preliminary revenue $6.8M (+32% YoY); guides FY2024 revenue $28-32M
--------------------------------------------------------------------------------

- Preliminary Q4 revenue $6.8M, up 32% YoY; biologics/drug delivery revenue $4.1M (+76% YoY).
- Full year 2023 record revenue ~$24M (+17% YoY); biologics/drug delivery $13.6M (+49% YoY).
- Cash burn ~$1.2M in Q4; cash and equivalents $23.1M at Dec 31, 2023.
- FY2024 revenue guidance $28-32M (17-33% growth); expects multiple product launches including SmartFrame OR and PRISM laser.
- Company plans to expand to 100 ClearPoint sites by 2025 and demonstrate operating leverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555024000016/0001285550-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555024000016/clpt-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001285550-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer